Skip to main content

Table 2 Frequently used drugs in the intensive care unit associated with abnormal movements listed in alphabetical order

From: Abnormal movements in critical care patients with brain injury: a diagnostic approach

Drug class

Abnormal movement type with specific drug if applicable

Analgesics

Seizures (meperidine and tramadol)

Clonus and myoclonus in the setting of serotonin syndrome (tramadol)

Antibiotics

Myoclonus and seizures with cefalosporins in renal failure

Seizures (fluoroquinolones and carbapenems)

Tremor (amphotericine)

Clonus in the setting of serotonin syndrome (linezolid)

Antidepressants and mood stabilizers

Seizures (SSRI, TCA and bupropione)

Tremor (lithium)

Chorea (lithium)

Antiepileptics

Tremor (valproic acid)

Ataxia and nystagmus (phenytoin)

Seizures may be seen with toxic doses (phenytoin)

Chorea (phenytoin, carbamazepine, valproic acid)

Antipsychotics

Seizures with almost all of them (especially clozapine)

Acute dystonic reaction affecting mainly the cervical, cranial and axial muscles seen most commonly with typical neuroleptics such as haloperidol

Neuroleptic malignant syndrome

Akasthesia

Tardive dyskinesia as a long-term effect

Tremor

Cardiovascular agents

Seizures (digoxin toxicity)

Tremor (amiodarone, procainamide)

Contrast agents

Seizures (diatrizoic acid)

Hormones

Tremor (levothyroxine, epinephrine)

Chorea (levothyroxine)

Gastrointestinal agents

Acute dystonic reaction (metoclopramide)

Neuroleptic malignant syndrome (metoclopramide)

Tardive dyskinesia as a long-term effect (metoclopramide)

Tremor (metoclopramide, cimetidine)

Chorea (metoclopramide)

Misused drugs

Seizures (alcohol withdrawal, cocaine and amphetamine toxicity)

Tremor (same drugs that cause seizures)

Chorea (amphetamine, cocaine)

  1. List of abnormal movements associated with each class of frequently administered medication in the intensive care unit setting. Examples refer to most frequently associated drug with abnormal movement type. SSRI selective serotonin reuptake inhibitor, TCA tricyclic antidepressant